Dopamine deficits and regualtion of the cAMP second messenger system in brains of simian immunodeficiency virus-infected rhesus monkeys

Journal of NeuroVirology

Volumn 10, Issue 3, 2004, Pages 163-170

  Jenuwein, M ^a   Scheller, C ^a   Neuen Jacob, E ^b   Sopper, S ^a   Tatschner, T ^a   ter Meulen, V ^a   Riederer, P ^a   Koutsilieri, Eleni ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Brain; cAMP; CREB; Dementia; Dopamine; HIV; Monkeys; SIV

Indexed keywords

CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE; 3,4 DIHYDROXYPHENYLACETIC ACID; HOMOVANILLIC ACID;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMENTIA; DOPAMINERGIC SYSTEM; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHESUS MONKEY; SECOND MESSENGER; SIMIAN IMMUNODEFICIENCY VIRUS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS LOAD; ANIMAL; BRAIN; MACACA; METABOLISM; MONKEY DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; SIGNAL TRANSDUCTION; VIROLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MACACA MULATTA; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HOMOVANILLIC ACID; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; SIGNAL TRANSDUCTION; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 3042844202     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280490448016     Document Type: Article

References (44)

1. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, Dawson TM, Dawson VL (1996). Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 274: 1917-1921.
2. Aloisi F, De Simone R, Columba-Cabezas S, Levi G (1999). Opposite effects of interferon-gamma and prostaglandin E2 on tumor necrosis factor and interleukin-10 production in microglia: a regulatory loop controlling microglia pro- and anti-inflammatory activities. J Neurosci Res 56: 571-580.
3. Arendt G, Hefter H, Elsing C, Strohmeyer G, Freund HJ (1990). Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. J Neurol 237: 362-368.
4. Aylward EH, Henderer JD, McArthur JC, Brettschneider PD, Harris GJ, Barta PE, Pearlson GD (1993). Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology 43: 2099-2104.
5. Berger JR, Arendt G (2000). HIV dementia: the role of the basal ganglia and dopaminergic systems. J Psychopharmacol 14: 214-221.
6. Berger JR, Nath A (1997). HIV dementia and the basal ganglia. Intervirology 40: 122-131.
7. Biswas DK, Ahlers CM, Dezube BJ, Pardee AB (1994). Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Mol Med 1: 31-43.
8. Bradford MM (1976). Rapid and sensitive method for quantitation of microgram quantities of proteins utilizing principle of protein dye binding. Anal Biochem 72: 248-254.
9. Cornford ME, Holden JK, Boyd MC, Berry K, Vinters HV (1992). Neuropathology of the acquired immune deficiency syndrome (AIDS): report of 39 autopsies from Vancouver, British Columbia. Can J Neurol Sci 19: 442-452.
10. Czub S, Koutsilieri E, Sopper S, Czub M, Stahl-Hennig C, Muller JG, Pedersen V, Gsell W, Heeney JL, Gerlach M, Gosztonyi G, Riederer P, ter Meulen V (2001). Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs. Acta Neuropathol (Berl) 101: 85-91.
11. Dowlatshahi D, MacQueen GM, Wang JF, Young LT (1998). Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 352: 1754-1755.
12. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597-606.
13. Fibiger HC (1984). The neurobiological substrates of depression in Parkinson's disease: a hypothesis. Can J Neurol Sci 11: 105-107.
14. Gerlach M, Youdim MB, Riederer P (1994). Is selegiline neuroprotective in Parkinson's disease? J Neural Transm Suppl 41: 177-188.
15. Gsell W, Lange K, Pfeuffer L, Heckers S, Heinsen H, Senitz D, Jellinger K, Ransmayr G, Wichart R, Vock R, Beckmann H, Riederer P (1993). How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm (Suppl) 39: 31-70.
16. Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991). BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350: 230-232.
17. Klimek V, Schenck JE, Han H, Stockmeier CA, Ordway GA (2002). Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study. Biol Psychiatry 52: 740-748.
18. Koutsilieri E, Scheller C, Sopper S, Ter Meulen V, Riederer P (2002a). Psychiatric complications in human immunodeficiency virus infection. J NeuroVirol 8 (Suppl 2): 129-133.
19. Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002b). Involvement of dopamine in the progression of AIDS Dementia Complex. J Neural Transm 109: 399-410.
20. Koutsilieri E, Sopper S, Scheller C, ter Meulen V, Riederer P (2002c). Parkinsonism in HIV dementia. J Neural Transm 109: 767-775.
21. Kure K, Weidenheim KM, Lyman WD, Dickson DW (1990). Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 80: 393-400.
22. Lopez OL, Smith G, Meltzer CC, Becker JT (1999). Dopamine systems in human immunodeficiency virus-associated dementia. Neuropsychiatry Neuropsychol Behav Neurol 12: 184-192.
23. Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G (1997). Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19: 152-160.
24. Montminy M (1997). Transcriptional regulation by cyclic AMP. Annu Rev Biochem 66: 807-822.
25. Nath A, Anderson C, Jones M, Maragos W, Booze R, Mactutus C, Bell J, Hauser KF, Mattson M (2000). Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia. J Psychopharmacol 14: 222-227.
26. Navia B, Cho E, Petito C, et al (1986). The AIDS dementia complex. II. Neuropathology. Annals of Neurology 19: 525-535.
27. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002). Neurobiology of depression. Neuron 34: 13-25.
28. Nuovo G, Alfieri M (1996). AIDS dementia is associated with massive, activated HIV-1 infection and concomittant expression of several cytokines. Mol Med 2: 358-366.
29. Patrizio M, Colucci M, Levi G (2001). Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures. J Neurochem 77: 399-407.
30. Reyes MG, Faraldi F, Senseng CS, Flowers C, Fariello R (1991). Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 82: 39-44.
31. Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos JZ, Price RW (1987). The metabolic pathology of the AIDS dementia complex. Ann Neurol 22: 700-706.
32. Sardar A, Czudek C, Reynolds G (1996). Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 7: 910-912.
33. Sauermann U, Krawczak M, Hunsmann G, Stahl-Hennig C (1997). Identification of Mhc-Mamu-DQB1 allele combinations associated with rapid disease progression in rhesus macaques infected with simian immunodeficiency virus. AIDS 11:1196-1198.
34. Senogles SE, Amlaiky N, Berger JG, Caron MG (1988). Biochemical properties of D1 and D2 dopamine receptors. Adv Exp Med Biol 235: 33-41.
35. Sopper S, Koutsilieri E, Scheller C, Czub S, Riederer P, ter Meulen V (2002). Macaque animal model for HIV-induced neurological disease. J Neural Transm 109: 747-766.
36. Sopper S, Nierwetberg D, Halbach A, Sauer U, Scheller C, Stahl-Hennig C, Matz-Rensing K, Schafer F, Schneider T, ter Meulen V, Muller JG (2003). Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys. Blood 101: 1213-1219.
37. Suzumura A, Ito A, Yoshikawa M, Sawada M (1999). Ibudilast suppresses TNFalpha production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Res 837: 203-212.
38. Treisman G, Fishman M, Schwartz J, Hutton H, Lyketsos C (1998). Mood disorders in HIV infection. Depress Anxiety 7: 178-187.
39. Tyor WR, Glass JD, Griffin JW, Becker PS, McArthur JC, Bezman L, Griffin DE (1992). Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31: 349-360.
40. Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T (2003). Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm 110: 671-680.
41. Yamamoto-Sasaki M, Ozawa H, Saito T, Rosler M, Riederer P (1999). Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824: 300-303.
42. Zafra F, Lindholm D, Castren E, Hartikka J, Thoenen H (1992). Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes. J Neurosci 12: 4793-4799.
43. Zauli G, Milani D, Mirandola P, Mazzoni M, Secchiero P, Miscia S, Capitani S (2001). HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway. Faseb J 15: 483-491.
44. Zauli G, Secchiero P, Rodella L, Gibellini D, Mirandola P, Mazzoni M, Milani D, Dowd DR, Capitani S, Vitale M (2000). HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells. J Biol Chem 275: 4159-4165.